Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioHarvest Sciences ( (BHST) ) has shared an update.
BioHarvest Sciences announced that it will release its second quarter 2025 financial results on August 11, 2025, before the market opens. The company will host an investor conference call and webcast on the same day to discuss the results and provide a corporate update, which may impact its market positioning and stakeholder engagement.
The most recent analyst rating on (BHST) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences shows robust revenue growth and positive momentum but is hindered by financial instability and unprofitability. The strong earnings call reflects strategic growth initiatives, partially offsetting financial risks. Technical indicators suggest positive momentum, but valuation concerns persist due to negative earnings.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology to produce plant-based compounds without growing the actual plant. The company operates in two main business areas: as a contract development and production organization for novel plant-based compounds and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
Average Trading Volume: 9,422
Technical Sentiment Signal: Buy
Current Market Cap: $133.2M
Find detailed analytics on BHST stock on TipRanks’ Stock Analysis page.